Colorectal cancer is the second leading cause of cancer-related death globally. Although some of the molecular changes ...

HELSINKI, May 13, 2025 (GLOBE NEWSWIRE) -- TILT Biotherapeutics (Tiltbio), a clinical-stage biotechnology company developing ...

Researchers at Baylor College of Medicine and collaborating institutions have uncovered a key molecular player that is ...

Researchers at Baylor College of Medicine and collaborating institutions have uncovered a key molecular player that is ...

First Trial Site Initiated for Phase 3 OVATION 3 Study of IMNN-001 in Newly Diagnosed Advanced Ovarian Cancer - On May 8, 2025, the Company announced initiation of the first trial site for the OVATION ...

Cancer treatment with a cell-based immunotherapy causes mild cognitive impairment, a Stanford Medicine team found. They also identified compounds that could treat it.

Swedish cancer patients treated with CAR T-cell therapy show better survival rates and fewer side effects than seen in ...

Researchers have discovered how to block cells dying, in a finding that could lead to new treatments for neurodegenerative conditions like Parkinson's and Alzheimer's. The team has identified a small ...